NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $387,029 | -40.4% | 9,326 | -13.7% | 0.02% | -44.4% |
| Q1 2023 | $649,692 | -16.1% | 10,803 | +2.3% | 0.03% | -20.6% |
| Q4 2022 | $774,576 | -4.4% | 10,560 | -0.9% | 0.03% | -10.5% |
| Q3 2022 | $810,000 | +8.4% | 10,657 | -0.8% | 0.04% | +5.6% |
| Q2 2022 | $747,000 | -10.9% | 10,742 | -3.7% | 0.04% | +2.9% |
| Q4 2021 | $838,000 | -39.5% | 11,159 | -6.4% | 0.04% | -47.0% |
| Q3 2021 | $1,385,000 | -38.3% | 11,923 | +0.9% | 0.07% | -40.5% |
| Q2 2021 | $2,243,000 | +41.9% | 11,821 | -0.3% | 0.11% | +23.3% |
| Q1 2021 | $1,581,000 | -31.8% | 11,859 | -11.4% | 0.09% | -46.4% |
| Q4 2020 | $2,317,000 | +63.4% | 13,392 | +5.1% | 0.17% | +32.3% |
| Q3 2020 | $1,418,000 | +75.9% | 12,739 | -6.3% | 0.13% | +56.8% |
| Q2 2020 | $806,000 | -38.5% | 13,589 | -30.2% | 0.08% | -54.2% |
| Q1 2020 | $1,311,000 | +1.5% | 19,467 | +27.0% | 0.18% | +9.3% |
| Q4 2019 | $1,292,000 | +23.5% | 15,329 | +9.6% | 0.16% | -1.2% |
| Q3 2019 | $1,046,000 | +10.9% | 13,985 | -6.2% | 0.16% | +3.8% |
| Q2 2019 | $943,000 | +28.8% | 14,915 | -1.9% | 0.16% | +42.3% |
| Q1 2019 | $732,000 | – | 15,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |